Successful anti‐CD19 CAR T‐cell therapy in HIV‐infected patients with refractory high‐grade B‐cell lymphoma

Expanding Access to Cancer Clinical Trials for Patients With Mental Illness

(2019) Kelly E. Irwin et al.   JOURNAL OF CLINICAL ONCOLOGY

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma

(2018) Stephen J. Schuster et al.   NEW ENGLAND JOURNAL OF MEDICINE

Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology–Friends of Cancer Research HIV Working Group

(2017) Thomas S. Uldrick et al.   JOURNAL OF CLINICAL ONCOLOGY

Reevaluating Eligibility Criteria — Balancing Patient Protection and Participation in Oncology Trials

(2017) Julia A. Beaver et al.   NEW ENGLAND JOURNAL OF MEDICINE

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

(2017) Sattva S. Neelapu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Homology-Directed Recombination for Enhanced Engineering of Chimeric Antigen Receptor T Cells

(2017) Malika Hale et al.   Molecular Therapy-Methods & Clinical Development

Disparities in cancer treatment among patients infected with the human immunodeficiency virus

(2016) Gita Suneja et al.   CANCER

Elevated Cancer-Specific Mortality Among HIV-Infected Patients in the United States

(2015) Anna E. Coghill et al.   JOURNAL OF CLINICAL ONCOLOGY

Current concepts in the diagnosis and management of cytokine release syndrome

(2014) D. W. Lee et al.   BLOOD

Reduced-intensity conditioning allogeneic stem cell transplantation in HIV patients with hematologic malignancies: yes, we can

(2009) M. Hamadani et al.   BLOOD

Including Persons With HIV Infection in Cancer Clinical Trials

(2008) Govind C. Persad et al.   JOURNAL OF CLINICAL ONCOLOGY